Satellite Symposium SS04 (Sponsored by Vertex Pharmaceuticals Incorporated)

Transforming Anti-HCV Treatment: The Potential for Specifically Targeted Antiviral Therapy for HCV (STAT-C)

Sunday July 2, 18.00 - 19.30

This meeting is CME accredited by Projects In Knowledge, peer reviewed by the University of Pennsylvania School of Medicine and funded by Vertex Pharmaceuticals Incorporated.

CHAIR

Alfredo Alberti, MD Professor of Internal Medicine and Gastroenterology University of Padova Padova, Italy

FACULTY

Yves Benhamou, MD Associate Professor of Hepatology Service d’Hepato-Gastro-Enterologie Groupe Hospitalier Pitie-Salpetriere Paris, France

John G. McHutchison, MD, FRACP Professor of Medicine Director, Gastroenterology/Hepatology Research Duke University Medical Center Durham, North Carolina

Stefan Zeuzem, MD Professor of Medicine Department of Internal Medicine II Gastroenterology, Hepatology, Endocrinology University Hospital Homburg/Saar, Germany

AGENDA

18:00 - 18:05
Introduction (Alfredo Alberti, MD)

18:05 - 18:25
Modeling, Kinetics, and Resistance Profiles of New Protease and Polymerase Inhibitors (Stefan Zeuzem, MD)

18:25 - 18:45
Update on Current Clinical Trial Results (Yves Benhamou, MD)

18:45 - 19:05
Clinical Implications of Treatment Paradigm Shifts in HCV (John G. McHutchison, MD, FRACP)

19:05 - 19:25
Q & A
Panel Discussion

19:25 - 19:30
Summary, Conclusions, and Close (Alfredo Alberti, MD)